BCL2 and diabetic kidney disease: In podocytes exposed to high glucose, a model for diabetic kidney disease, UA improved cell survival and decreased apoptosis through the Bcl-2/caspase-3 pathway (Figure 4) and by increasing autophagy markers [50].